Related Experiment Video
Updated: May 17, 2026

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
Published on: May 5, 2023
The role of the endothelium in long COVID
Leonardo Tamariz1, Lina A Shehadeh2, Elizabeth Bast3
1Department of Public Health Sciences, Miller School of Medicine at the University of Miami, Miami, FL, United States of America; GRECC, Geriatric Research Education and Clinical Center, Veterans Affairs Medical Center, Miami, FL, United States of America.
Insights
SARS-CoV2 infection elevates cardiovascular risk via endothelial dysfunction and inflammation. Vitamin C and L-arginine show promise in improving endothelial function in long COVID patients.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Vascular Biology
Background:
- SARS-CoV-2 infection is linked to increased cardiovascular event risk.
- Key mechanisms include systemic inflammation, dysautonomia, endothelial dysfunction, and prothrombotic states.
- The endothelium's role is critical, alongside dysautonomia and mast cell activation.
Purpose of the Study:
- To explore the mechanisms linking SARS-CoV-2 to cardiovascular risk.
- To identify methods for detecting endothelial dysfunction.
- To review potential treatments for endothelial dysfunction in long COVID.
Main Methods:
- Review of existing literature on SARS-CoV-2 and cardiovascular complications.
- Discussion of endothelial cell activation by SARS-CoV-2.
- Identification of flow-mediated dilation as a key diagnostic method.
- Summary of randomized trials for endothelial dysfunction treatments.
Main Results:
- SARS-CoV-2 induces a pro-inflammatory and pro-thrombotic endothelial phenotype.
- This can lead to microcirculatory dysfunction and reduced tissue oxygen delivery.
- Flow-mediated dilation is a primary method for assessing endothelial dysfunction.
- Antihypertensives, statins, beta-blockers, supplements, and lifestyle changes are established treatments.
- Limited studies suggest Vitamin C and L-arginine may improve flow-mediated dilation in long COVID.
Conclusions:
- Endothelial dysfunction is a significant contributor to cardiovascular risk post-SARS-CoV-2.
- Microcirculatory changes and impaired vasodilation are key consequences.
- Further research into supplements like Vitamin C and L-arginine for long COVID is warranted.
Abstract:
SARS-CoV2 infection significantly increases the risk of cardiovascular events through multiple interconnected mechanisms including systemic inflammation, dysautonomia, endothelial dysfunction, and prothrombotic states. The endothelium plays a critical role in this increase in risk together with dysautonomia and mast cell activation. SARS-CoV2 activates endothelial cells creating a pro-inflammatory, and pro-thrombotic phenotype. This phenotype could lead to microcirculatory changes that decrease oxygen delivery to tissues because of loss of laminar flow, lack of nitric oxide dependent vasodilation, increased viscosity and abnormal constriction of vascular smooth muscle cells due to neuropathy. There are several ways of identifying patients with endothelial dysfunction and the most used is flow mediated dilation. Many randomized trials have already found significant treatments for endothelial dysfunction and include antihypertensives, statins, beta-blockers, supplements and lifestyle interventions. Only two studies using vitamin C and L-arginine demonstrated improvements in flow mediated dilation in patients with long COVID.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Myocarditis I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Overview of the Vascular System

